{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T01:41:12Z","timestamp":1791855672541,"version":"4.3.4"},"reference-count":60,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"The Rehabilitation Research and Development Service of the Veteran\u2019s Health Administration","award":["I01RX002099"],"award-info":[{"award-number":["I01RX002099"]}]},{"DOI":"10.13039\/100012641","name":"Bryon Riesch Paralysis Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100012641","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Rehabilitation Research and Development Service of the Veteran\u2019s Health Administration","award":["I01RX002099"],"award-info":[{"award-number":["I01RX002099"]}]},{"name":"John M. and Jocelyn H.K. Watkins Distinguished Chair in Cell Therapies"},{"name":"Miami Project to Cure Paralysis"},{"DOI":"10.13039\/100001013","name":"Buoniconti Fund","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100001013","id-type":"DOI","asserted-by":"crossref"}]},{"id":[{"id":"https:\/\/ror.org\/033ha7p77","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Spinal cord injury (SCI) triggers a secondary injury cascade characterized by persistent innate immune activation, chronic neuroinflammation, and progressive tissue loss that limits functional recovery. Here, we evaluated a systemic combination treatment using propentofylline (PPF), a glial modulator, together with interleukin-4 (IL-4), a cytokine associated with repair-related myeloid responses. In vitro, PPF enhanced IL-4-dependent induction of arginase-1 (ARG1) in TNF\u03b1-primed BV2 microglia. In vivo, adult Fischer rats of both sexes received vehicle, PPF, IL-4, or combined PPF + IL-4 beginning within 1 h after moderate T8 contusive SCI and continuing daily for 14 days. Locomotor recovery was assessed longitudinally for 8 weeks, followed by histological and immunohistochemical analyses. Combined PPF + IL-4 treatment produced the greatest improvement in gross and skilled locomotor recovery compared with vehicle, or either monotherapy. At 8 weeks post-SCI, the combined therapy aligned with a reduction in chronic lesion-associated p-p38 MAPK, decreased pP65 NFkB (RelA) activation, increased expression of reparative factors ARG1 and CD206, as well as reduced lesion cavitation and trends toward greater gray and white matter preservation. Stratification of functional data by sex showed BBB improvements with combined PPF + IL-4 in both males and females after SCI. Together, these findings show that combined systemic PPF and IL-4 treatment was associated with improved functional recovery, reduced lesion cavitation, and changes in lesion-associated molecular and histological endpoints after SCI, supporting further preclinical investigation.<\/jats:p>","DOI":"10.3390\/cells15070625","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T14:09:54Z","timestamp":1775138994000},"page":"625","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Propentofylline and Interleukin-4 Modulate Lesion-Associated Myeloid Responses and Improve Functional Recovery After Spinal Cord Injury"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7779-158X","authenticated-orcid":false,"given":"Mousumi","family":"Ghosh","sequence":"first","affiliation":[{"name":"The Miami Project to Cure Paralysis, The University of Miami Miller School of Medicine, Miami, FL 33136, USA"},{"name":"The Department of Neurological Surgery, The University of Miami Miller School of Medicine, Miami, FL 33136, USA"},{"name":"The Neuroscience Program, The University of Miami Miller School of Medicine, Miami, FL 33136, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3784-0527","authenticated-orcid":false,"given":"Amir-Hossein","family":"Bayat","sequence":"additional","affiliation":[{"name":"The Miami Project to Cure Paralysis, The University of Miami Miller School of Medicine, Miami, FL 33136, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keeley S.","family":"Garvey","sequence":"additional","affiliation":[{"name":"The Miami Project to Cure Paralysis, The University of Miami Miller School of Medicine, Miami, FL 33136, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tolani","family":"Oshinusi","sequence":"additional","affiliation":[{"name":"The Miami Project to Cure Paralysis, The University of Miami Miller School of Medicine, Miami, FL 33136, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas De","family":"Leon","sequence":"additional","affiliation":[{"name":"The Miami Project to Cure Paralysis, The University of Miami Miller School of Medicine, Miami, FL 33136, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9742-7240","authenticated-orcid":false,"given":"Jacqueline","family":"Sagen","sequence":"additional","affiliation":[{"name":"The Miami Project to Cure Paralysis, The University of Miami Miller School of Medicine, Miami, FL 33136, USA"},{"name":"The Department of Neurological Surgery, The University of Miami Miller School of Medicine, Miami, FL 33136, USA"},{"name":"The Neuroscience Program, The University of Miami Miller School of Medicine, Miami, FL 33136, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien D.","family":"Pearse","sequence":"additional","affiliation":[{"name":"The Miami Project to Cure Paralysis, The University of Miami Miller School of Medicine, Miami, FL 33136, USA"},{"name":"The Department of Neurological Surgery, The University of Miami Miller School of Medicine, Miami, FL 33136, USA"},{"name":"The Neuroscience Program, The University of Miami Miller School of Medicine, Miami, FL 33136, USA"},{"name":"The Interdisciplinary Stem Cell Institute, The University of Miami Miller School of Medicine, Miami, FL 33136, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,3,31]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Guest, J., Datta, N., Jimsheleishvili, G., and Gater, D.R. (2022). Pathophysiology, Classification and Comorbidities after Traumatic Spinal Cord Injury. J. Pers. Med., 12.","DOI":"10.3390\/jpm12071126"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/s41392-023-01477-6","article-title":"Spinal cord injury: Molecular mechanisms and therapeutic interventions","volume":"8","author":"Hu","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Alvi, M.A., Pedro, K.M., Quddusi, A.I., and Fehlings, M.G. (2024). Advances and Challenges in Spinal Cord Injury Treatments. J. Clin. Med., 13.","DOI":"10.3390\/jcm13144101"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"42","DOI":"10.5312\/wjo.v6.i1.42","article-title":"Current and future medical therapeutic strategies for the functional repair of spinal cord injury","volume":"6","author":"Yilmaz","year":"2015","journal-title":"World J. Orthop."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3892\/mmr.2021.12056","article-title":"Acute spinal cord injury: Pathophysiology and pharmacological intervention (Review)","volume":"23","author":"Zhang","year":"2021","journal-title":"Mol. Med. Rep."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Anjum, A., Yazid, M.D., Fauzi Daud, M., Idris, J., Ng, A.M.H., Selvi Naicker, A., Ismail, O.H.R., Athi Kumar, R.K., and Lokanathan, Y. (2020). Spinal Cord Injury: Pathophysiology, Multimolecular Interactions, and Underlying Recovery Mechanisms. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21207533"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0079-6123(09)17508-8","article-title":"Neuroinflammation in spinal cord injury: Therapeutic targets for neuroprotection and regeneration","volume":"175","author":"Alexander","year":"2009","journal-title":"Prog. Brain Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1186\/s12974-021-02337-2","article-title":"Inflammation after spinal cord injury: A review of the critical timeline of signaling cues and cellular infiltration","volume":"18","author":"Hellenbrand","year":"2021","journal-title":"J. Neuroinflamm."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/cne.21149","article-title":"Proinflammatory cytokine synthesis in the injured mouse spinal cord: Multiphasic expression pattern and identification of the cell types involved","volume":"500","author":"Pineau","year":"2007","journal-title":"J. Comp. Neurol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.expneurol.2007.06.009","article-title":"Inflammation and its role in neuroprotection, axonal regeneration and functional recovery after spinal cord injury","volume":"209","author":"Donnelly","year":"2008","journal-title":"Exp. Neurol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2014.12.045","article-title":"Macrophage activation and its role in repair and pathology after spinal cord injury","volume":"1619","author":"Gensel","year":"2015","journal-title":"Brain Res."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Xu, L., Wang, J., Ding, Y., Wang, L., and Zhu, Y.J. (2021). Current Knowledge of Microglia in Traumatic Spinal Cord Injury. Front. Neurol., 12.","DOI":"10.3389\/fneur.2021.796704"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12974-015-0463-9","article-title":"Cyclic AMP is a key regulator of M1 to M2a phenotypic conversion of microglia in the presence of Th2 cytokines","volume":"13","author":"Ghosh","year":"2016","journal-title":"J. Neuroinflamm."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.immuni.2010.05.007","article-title":"Alternative activation of macrophages: Mechanism and functions","volume":"32","author":"Gordon","year":"2010","journal-title":"Immunity"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/1742-2094-11-98","article-title":"Neuroinflammation and M2 microglia: The good, the bad, and the inflamed","volume":"11","author":"Cherry","year":"2014","journal-title":"J. Neuroinflamm."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Fu, S.P., Chen, S.Y., Pang, Q.M., Zhang, M., Wu, X.C., Wan, X., Wan, W.H., Ao, J., and Zhang, T. (2022). Advances in the research of the role of macrophage\/microglia polarization-mediated inflammatory response in spinal cord injury. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.1014013"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.1038\/s41467-019-11707-7","article-title":"Moving beyond the glial scar for spinal cord repair","volume":"10","author":"Bradbury","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1152\/physrev.00017.2017","article-title":"The Biology of Regeneration Failure and Success After Spinal Cord Injury","volume":"98","author":"Tran","year":"2018","journal-title":"Physiol. Rev."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s13311-018-0631-6","article-title":"Spinal Cord Injury Scarring and Inflammation: Therapies Targeting Glial and Inflammatory Responses","volume":"15","author":"Orr","year":"2018","journal-title":"Neurotherapeutics"},{"key":"ref_20","first-page":"36467","article-title":"Immunomodulatory Strategies for Spinal Cord Injury","volume":"45","author":"Park","year":"2022","journal-title":"Biomed. J. Sci. Tech. Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"8904","DOI":"10.1523\/JNEUROSCI.1146-14.2014","article-title":"IL-4 signaling drives a unique arginase+\/IL-1beta+ microglia phenotype and recruits macrophages to the inflammatory CNS: Consequences of age-related deficits in IL-4Ralpha after traumatic spinal cord injury","volume":"34","author":"Fenn","year":"2014","journal-title":"J. Neurosci."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Lima, R., Monteiro, S., Lopes, J.P., Barradas, P., Vasconcelos, N.L., Gomes, E.D., Assuncao-Silva, R.C., Teixeira, F.G., Morais, M., and Sousa, N. (2017). Systemic Interleukin-4 Administration after Spinal Cord Injury Modulates Inflammation and Promotes Neuroprotection. Pharmaceuticals, 10.","DOI":"10.3390\/ph10040083"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1002\/glia.23041","article-title":"IL-4 drives microglia and macrophages toward a phenotype conducive for tissue repair and functional recovery after spinal cord injury","volume":"64","year":"2016","journal-title":"GLIA"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"4726","DOI":"10.7150\/thno.123815","article-title":"Systemic Interleukin-4 Application Promotes Functional Recovery and Reprograms Neuroinflammatory and Molecular Responses after Spinal Cord Injury in Rats","volume":"16","author":"Alhalabi","year":"2026","journal-title":"Theranostics"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Nascimento, D., Ferreira, A., and Cruz, C.D. (2025). Immune Activation Following Spinal Cord Injury: A Review Focused on Inflammatory Changes in the Spinal Cord. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26199624"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.pain.2008.01.021","article-title":"Propentofylline attenuates allodynia, glial activation and modulates GABAergic tone after spinal cord injury in the rat","volume":"138","author":"Gwak","year":"2008","journal-title":"Pain"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Sweitzer, S., and De Leo, J. (2011). Propentofylline: Glial modulation, neuroprotection, and alleviation of chronic pain. Methylxanthines. Handbook of Experimental Pharmacology, Springer.","DOI":"10.1007\/978-3-642-13443-2_8"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.bbi.2006.07.001","article-title":"Efficacy of propentofylline, a glial modulating agent, on existing mechanical allodynia following peripheral nerve injury","volume":"21","author":"Tawfik","year":"2007","journal-title":"Brain Behav. Immun."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/neuonc\/nor194","article-title":"Propentofylline decreases tumor growth in a rodent model of glioblastoma multiforme by a direct mechanism on microglia","volume":"14","author":"Jacobs","year":"2012","journal-title":"Neuro-Oncology"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0165-5728(90)90073-V","article-title":"Immortalization of murine microglial cells by a v-raf\/v-myc carrying retrovirus","volume":"27","author":"Blasi","year":"1990","journal-title":"J. Neuroimmunol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"83","DOI":"10.14573\/altex.2009.2.83","article-title":"The suitability of BV2 cells as alternative model system for primary microglia cultures or for animal experiments examining brain inflammation","volume":"26","author":"Henn","year":"2009","journal-title":"ALTEX"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Bayat, A.H., Pearse, D.D., Singh, P.K., and Ghosh, M. (2026). Comparative Profiling of Mouse and Human Microglial Small Extracellular Vesicles Reveals Conserved Core Functions with Distinct miRNA Signatures. Cells, 15.","DOI":"10.3390\/cells15020184"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1002\/glia.22401","article-title":"Proinflammatory cytokine regulation of cyclic AMP-phosphodiesterase 4 signaling in microglia in vitro and following CNS injury","volume":"60","author":"Ghosh","year":"2012","journal-title":"GLIA"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"308461","DOI":"10.1155\/2015\/308461","article-title":"The interplay between cyclic AMP, MAPK, and NF-\u03baB pathways in response to proinflammatory signals in microglia","volume":"2015","author":"Ghosh","year":"2015","journal-title":"Biomed. Res. Int."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Ghosh, M., Lee, J., Burke, A.N., Strong, T.A., Sagen, J., and Pearse, D.D. (2024). Sex Dependent Disparities in the Central Innate Immune Response after Moderate Spinal Cord Contusion in Rat. Cells, 13.","DOI":"10.3390\/cells13070645"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Pearse, D.D., Bastidas, J., Izabel, S.S., and Ghosh, M. (2018). Schwann Cell Transplantation Subdues the Pro-Inflammatory Innate Immune Cell Response after Spinal Cord Injury. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19092550"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1002\/glia.22330","article-title":"Extensive cell migration, axon regeneration, and improved function with polysialic acid-modified Schwann cells after spinal cord injury","volume":"60","author":"Ghosh","year":"2012","journal-title":"GLIA"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/S0022-3565(24)29652-X","article-title":"Propentofylline, a glial modulating agent, exhibits antiallodynic properties in a rat model of neuropathic pain","volume":"297","author":"Sweitzer","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1476-5381.1991.tb12443.x","article-title":"Neuroprotective activity of chlormethiazole following transient forebrain ischaemia in the gerbil","volume":"104","author":"Cross","year":"1991","journal-title":"Br. J. Pharmacol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1006\/exnr.1996.0098","article-title":"Graded histological and locomotor outcomes after spinal cord contusion using the NYU weight-drop device versus transection","volume":"139","author":"Basso","year":"1996","journal-title":"Exp. Neurol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s40478-025-02135-4","article-title":"Removal or inhibition of transglutaminase 2 decreases cellular stress, supporting tissue preservation, and recovery after SCI","volume":"14","author":"Ghosh","year":"2025","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1089\/neu.2005.22.680","article-title":"Histopathological and behavioral characterization of a novel cervical spinal cord displacement contusion injury in the rat","volume":"22","author":"Pearse","year":"2005","journal-title":"J. Neurotrauma"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/cne.22014","article-title":"Systemic hypothermia improves histological and functional outcome after cervical spinal cord contusion in rats","volume":"514","author":"Lo","year":"2009","journal-title":"J. Comp. Neurol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0006-8993(98)00954-8","article-title":"Differential regulation of microglial activation by propentofylline via cAMP signaling","volume":"812","author":"Si","year":"1998","journal-title":"Brain Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1161\/01.STR.19.12.1535","article-title":"Protection against ischemic brain damage using propentofylline in gerbils","volume":"19","author":"DeLeo","year":"1988","journal-title":"Stroke"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.expneurol.2009.08.012","article-title":"Activation of p-38\u03b1 MAPK contributes to neuronal hyperexcitability in caudal regions remote from spinal cord injury","volume":"220","author":"Gwak","year":"2009","journal-title":"Exp. Neurol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.expneurol.2011.11.006","article-title":"Propentofylline, a CNS glial modulator does not decrease pain in post-herpetic neuralgia patients: In vitro evidence for differential responses in human and rodent microglia and macrophages","volume":"234","author":"Landry","year":"2012","journal-title":"Exp. Neurol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"71","DOI":"10.12703\/r\/10-71","article-title":"Recent advances in understanding the role of IL-4 signaling","volume":"10","author":"Keegan","year":"2021","journal-title":"Fac. Rev."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Monteiro, J.P., Alves, M.G., Oliveira, P.F., and Silva, B.M. (2016). Structure-Bioactivity Relationships of Methylxanthines: Trying to Make Sense of All the Promises and the Drawbacks. Molecules, 21.","DOI":"10.3390\/molecules21080974"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1007\/BF02976760","article-title":"Pharmacokinetics of propentofylline and the quantitation of its metabolite hydroxypropentofylline in human volunteers","volume":"21","author":"Kwon","year":"1998","journal-title":"Arch. Pharm. Res."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Shechter, R., London, A., Varol, C., Raposo, C., Cusimano, M., Yovel, G., Rolls, A., Mack, M., Pluchino, S., and Martino, G. (2009). Infiltrating blood-derived macrophages are vital cells playing an anti-inflammatory role in recovery from spinal cord injury in mice. PLoS Med., 6.","DOI":"10.1371\/journal.pmed.1000113"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"114908","DOI":"10.1016\/j.celrep.2024.114908","article-title":"Deep proteomic analysis of microglia reveals fundamental biological differences between model systems","volume":"43","author":"Lloyd","year":"2024","journal-title":"Cell Rep."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"101651","DOI":"10.1016\/j.smim.2022.101651","article-title":"Redefining microglia states: Lessons and limits of human and mouse models to study microglia states in neurodegenerative diseases","volume":"60","author":"Therrien","year":"2022","journal-title":"Semin. Immunol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1749-6632.1997.tb48481.x","article-title":"Clinical trials in dementia with propentofylline","volume":"826","author":"Kittner","year":"1997","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Frampton, M., Harvey, R.J., and Kirchner, V. (2003). Propentofylline for dementia. Cochrane Database Syst. Rev., CD002853.","DOI":"10.1002\/14651858.CD002853"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1159\/000051188","article-title":"Propentofylline in the treatment of Alzheimer\u2019s disease and vascular dementia: A review of phase III trials","volume":"9","author":"Rother","year":"1998","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1159\/000106650","article-title":"A 12-month, randomized, placebo-controlled trial of propentofylline (HWA 285) in patients with dementia according to DSM III-R","volume":"8","author":"Marcusson","year":"1997","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Simon, K.E., Gruen, M.E., and Olby, N.J. (2025). Current practices for diagnosis and management of Canine Cognitive Dysfunction Syndrome in the United States. Front. Vet. Sci., 12.","DOI":"10.3389\/fvets.2025.1685430"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/0959-8049(93)90108-R","article-title":"Recombinant human interleukin-4 (rhu IL-4) administered by the intravenous and subcutaneous routes in patients with advanced cancer\u2014A phase I toxicity study and pharmacokinetic analysis","volume":"29","author":"Prendiville","year":"1993","journal-title":"Eur. J. Cancer"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/00002371-200207000-00007","article-title":"Phase II trial of recombinant human interleukin-4 in patients with advanced renal cell carcinoma: A southwest oncology group study","volume":"25","author":"Whitehead","year":"2002","journal-title":"J. Immunother."}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/15\/7\/625\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T04:22:56Z","timestamp":1775190176000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/15\/7\/625"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,31]]},"references-count":60,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["cells15070625"],"URL":"https:\/\/doi.org\/10.3390\/cells15070625","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,31]]}}}